Zahornacký Ondrej, Novotný Martin
Department of Infectious Diseases and Travel Medicine, Faculty of Medicine, Pavel Josef Safarik´s University and University Hospital in Košice, Slovak Republic, e-mail:
Klin Mikrobiol Infekc Lek. 2020 Jun;26(2):51-53.
The article discusses dalbavancin, a relatively new lipoglycopeptide antibiotic brought to market. It briefly describes the spectrum and mechanism of its antibacterial effect and dosing regimens that can be used in the treatment of skin and soft tissue infections. The authors present a case of a patient with shoulder phlegmon caused by MRSA who was successfully treated with this antibiotic.
本文讨论了达巴万星，一种相对较新的上市脂糖肽类抗生素。它简要描述了其抗菌作用的谱和机制以及可用于治疗皮肤和软组织感染的给药方案。作者介绍了一例由耐甲氧西林金黄色葡萄球菌（MRSA）引起的肩部蜂窝织炎患者，该患者用这种抗生素成功治愈。
